Original Research
Accepted on 27 Aug 2024
Development of transcriptomic tools for predicting the response to individual drug of the mFOLFIRINOX regimen in patients with metastatic pancreatic cancer
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers